Literature DB >> 16527886

Butyrylcholinesterase activity, cardiovascular risk factors, and mortality in middle-aged and elderly men and women in Jerusalem.

Ronit Calderon-Margalit1, Bella Adler, Joseph H Abramson, Jaime Gofin, Jeremy D Kark.   

Abstract

BACKGROUND: The association of butyrylcholinesterase (BuChE) with Alzheimer disease and the association of this disease with cardiovascular risk factors raise interest in the association of BuChE activity with cardiovascular risk factors and mortality.
METHODS: A baseline cross-sectional study was conducted between 1985 and 1987, encompassing residents > or =50 years of age living in a Jewish neighborhood in western Jerusalem. Interviews were followed by examinations and nonfasting blood sampling (available for 1807 participants). Follow-up data to April 1996 on mortality and causes of death were obtained through record linkage with the Israeli Population Registry.
RESULTS: BuChE activity was inversely related to age and was positively associated with serum concentrations of albumin (r = 0.35; P <0.001), cholesterol (r = 0.31; P <0.001), and triglycerides (r = 0.30; P <0.001). Enzyme activity was associated with measures of overweight, obesity, and body fat distribution (e.g., body mass index, r = 0.20; P <0.001). In multivariate analysis, the associations of enzyme activity with serum cholesterol, triglycerides, and albumin persisted strongly. After adjustment by Cox proportional hazards regression for other predictors of mortality in this population, individuals in the lowest quintile of BuChE activity had significantly higher mortality than those in the highest quintile [hazard ratios (95% confidence intervals): all-cause mortality, 1.62 (1.15-2.30); cardiovascular deaths, 1.79 (1.05-3.05)]. The association was attenuated by introduction of serum albumin into the models.
CONCLUSIONS: This is the first study to report on the association between BuChE and mortality. The relatively strong association of BuChE with serum lipid and albumin concentrations requires elucidation. Our results suggest that low BuChE activity may be a nonspecific risk factor for mortality in the elderly.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16527886     DOI: 10.1373/clinchem.2005.059857

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  21 in total

1.  PON1 status does not influence cholinesterase activity in Egyptian agricultural workers exposed to chlorpyrifos.

Authors:  Corie A Ellison; Alice L Crane; Matthew R Bonner; James B Knaak; Richard W Browne; Pamela J Lein; James R Olson
Journal:  Toxicol Appl Pharmacol       Date:  2012-09-10       Impact factor: 4.219

Review 2.  Genetic insights into cardiometabolic risk factors.

Authors:  John B Whitfield
Journal:  Clin Biochem Rev       Date:  2014-02

3.  GWAS of butyrylcholinesterase activity identifies four novel loci, independent effects within BCHE and secondary associations with metabolic risk factors.

Authors:  Beben Benyamin; Rita P Middelberg; Penelope A Lind; Anne M Valle; Scott Gordon; Dale R Nyholt; Sarah E Medland; Anjali K Henders; Andrew C Heath; Pamela A F Madden; Peter M Visscher; Daniel T O'Connor; Grant W Montgomery; Nicholas G Martin; John B Whitfield
Journal:  Hum Mol Genet       Date:  2011-08-23       Impact factor: 6.150

4.  Decline in serum cholinesterase activities predicts 2-year major adverse cardiac events.

Authors:  Yaron Arbel; Shani Shenhar-Tsarfaty; Nir Waiskopf; Ariel Finkelstein; Amir Halkin; Miri Revivo; Shlomo Berliner; Itzhak Herz; Itzhak Shapira; Gad Keren; Hermona Soreq; Shmuel Banai
Journal:  Mol Med       Date:  2014-02-12       Impact factor: 6.354

Review 5.  Cholinesterases as biomarkers for parasympathetic dysfunction and inflammation-related disease.

Authors:  Shani Shenhar-Tsarfaty; Shlomo Berliner; Natan M Bornstein; Hermona Soreq
Journal:  J Mol Neurosci       Date:  2013-11-20       Impact factor: 3.444

6.  Low serum butyrylcholinesterase is independently related to low fetuin-A in patients on hemodialysis: a cross-sectional study.

Authors:  Teppei Okamoto; Chikako Tsutaya; Shingo Hatakeyama; Sakae Konishi; Kazutaka Okita; Yoshimi Tanaka; Kengo Imanishi; Tooru Takashima; Fumitada Saitoh; Tadashi Suzuki; Chikara Ohyama
Journal:  Int Urol Nephrol       Date:  2018-08-20       Impact factor: 2.370

7.  Environmental exposure and effects on health of children from a tobacco-producing region.

Authors:  Sabrina N Nascimento; Gabriela Göethel; Marília Baierle; Anelise Barth; Natália Brucker; Mariele F Charão; Angela M Moro; Bruna Gauer; Elisa Sauer; Juliano Durgante; Marcelo D Arbo; Flavia V Thiesen; Tatiana D Saint' Pierre; Adriana Gioda; Rafael Moresco; Solange Cristina Garcia
Journal:  Environ Sci Pollut Res Int       Date:  2016-11-12       Impact factor: 4.223

8.  Plasma butyrylcholinesterase regulates ghrelin to control aggression.

Authors:  Vicky Ping Chen; Yang Gao; Liyi Geng; Robin J Parks; Yuan-Ping Pang; Stephen Brimijoin
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

9.  Butyrylcholinesterase level as an independent factor of erythropoiesis-stimulating agent resistance in patients on maintenance hemodialysis: a single-center cross-sectional study.

Authors:  Teppei Okamoto; Shingo Hatakeyama; Yoshimi Tanaka; Kengo Imanishi; Tooru Takashima; Fumitada Saitoh; Takuya Koie; Tadashi Suzuki; Chikara Ohyama
Journal:  Clin Exp Nephrol       Date:  2018-03-29       Impact factor: 2.801

Review 10.  Cholinergic activity as a new target in diseases of the heart.

Authors:  Ashbeel Roy; Silvia Guatimosim; Vania F Prado; Robert Gros; Marco A M Prado
Journal:  Mol Med       Date:  2015-01-26       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.